Report #2851293

Received Jul 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 74 yrs
State: NC
Recovered: Unknown
Vaccinated: Jul 15, 2025
Onset: Jul 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	CE9C9	—

Symptoms (1)

Expired product administered

Symptom narrative

administered a dose of Arexvy that was expired on July 6th 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 74-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number CE9C9, expiry date 06-JUL-2025) for prophylaxis. On 15-JUL-2025, the patient received Arexvy. On 15-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: administered a dose of Arexvy that was expired on July 6th 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 15-JUL-2025 On 15 Jul 2025, a pharmacist called to inform that earlier that day, they had administered a dose of Arexvy that was expired on 06 July 2025 which led to Expired vaccine administered. No further details provided.